Artivion (AORT) CEO sells stock near $29 in recent trade

Rhea-AI Filing Summary

ARTIVION, INC. (AORT) reported that President & CEO James P. Mackin sold 70,000 shares of common stock on 2026-08-19 in an open market or private transaction. The shares were sold at a weighted average price of $28.955 per share, with individual sale prices ranging from $28.89 to $29.15. Following this transaction, Mackin directly holds 877,275 shares of ARTIVION common stock. The transaction was not marked as made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 70,000 shares

Net Sell 1 txn

Insider Mackin James P

Role President & CEO

Sold 70,000 shs ($2.03M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	70,000	$28.955	$2.03M

Holdings After Transaction: Common Stock — 877,275 shares (Direct)

Footnotes (1)

1. F1. Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 70,000 shares Weighted average sale price: $28.955 per share Post-transaction holdings: 877,275 shares +1 more

4 metrics

Shares sold 70,000 shares Non-derivative common stock sale on 2026-08-19

Weighted average sale price $28.955 per share Reported for the 70,000-share sale of common stock

Post-transaction holdings 877,275 shares Directly owned common shares after the 2026-08-19 sale

Sale price range $28.89–$29.15 per share Range of individual trade prices referenced in the footnote

Key Terms

weighted average price, open market or private transaction, non-derivative

3 terms

weighted average price financial

"Reflects weighted average price. Range of prices were between $28.89 to $29.15."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

non-derivative financial

"transaction_type: non-derivative"

FAQ

What insider transaction did AORT report for President & CEO James P. Mackin?

ARTIVION (AORT) reported that President & CEO James P. Mackin sold 70,000 shares of common stock on 2026-08-19. The transaction is coded as a sale in an open market or private transaction and is reported as directly owned shares.

At what price did James P. Mackin sell AORT shares in this Form 4 filing?

James P. Mackin sold AORT common stock at a weighted average price of $28.955 per share. A footnote explains that actual prices for individual trades ranged between $28.89 and $29.15, and detailed trade breakdowns are available upon request to appropriate parties.

How many AORT shares does James P. Mackin hold after the reported sale?

After selling 70,000 shares, James P. Mackin directly holds 877,275 AORT common shares. This figure represents his reported direct ownership position immediately following the 2026-08-19 transaction and is disclosed as part of the Form 4 non-derivative transaction table.

Was the AORT insider sale by James P. Mackin made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked, so the sale was not affirmed as made under a 10b5-1 trading plan. No footnote describes the transaction as pursuant to any pre-arranged trading arrangement for this reported sale.

What does the price range disclosed in the AORT Form 4 footnote mean?

The footnote states the sale used a weighted average price with individual trades between $28.89 and $29.15. It explains that multiple trades occurred within this range and that full information on shares sold at each specific price is available upon request to qualified parties.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 02:11 PM Accepted by SEC EDGAR 08/20/2026 - 02:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mackin James P

(Last) (First) (Middle)

ARTIVION, INC.

1655 ROBERTS BLVD, NW

(Street)

KENNESAW GEORGIA 30144

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2026		S		70,000	D	$28.955(1)	877,275	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ James P. Mackin	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)